Forgent Power: Offering Consists of 29M Class A Shares Offered by Parent Entities of Company Controlled by Neos Partners and 14.6M Class A Shares Stock Offered by Forgent >FPS
Forgent Power: Public Offering of Class A Stock Priced at $49.00 Each >FPS
Forgent Power: Selling Stockholders, Company Granted Underwriters 30-Day Option to Purchase Up to an Additional 4.4M Shares and 2.2M Shares, Respectively, of Class A Common Stock at Public Offering Price >FPS
Wider Todd, a Director, reported direct sales of Common Stock in two transactions on 2026-06-29 and 2026-06-30. The sales were reported with weighted average prices of $6.25 and $6.12 per share, respectively. The total sale amount reported was $618,500. Following the reported transactions, Wider To…
Ark Invest increased its holdings in Circle and Bullish shares yesterday, based on tracking data.According to Foresight News, Ark Invest Tracker data show that Cathie Wood’s Ark Invest bought 287,609 shares of Circle stock and 27,740 shares of Bullish stock.
Shares of Hims & Hers Health, Inc. (HIMS) hit a fresh 2026 high after the company entered into a new financing arrangement with JPMorgan Chase that provides up to $400 million in liquidity, with the rally further driven by improving GLP-1 traction and renewed investor interest in its peptide opport…
Chevron Australia:
Forgent Power Solutions, Inc NYSE:FPS:
MELBOURNE, Australia and INDIANAPOLIS, July 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals ASX:TLX, NASDAQ:TLX, “Telix”) today announced the successful outcome of a Type B meeting with the United States (U.S.) Food and Drug Administration (FDA) to review the Part 1 safety and dosimetry data and…
By Sam Schechner, Meghan Bobrowsky and Amrith RamkumarSAN FRANCISCO — Like much of the tech world, startup founder Quinn Slack was riled up.It was just hours after the Trump administration on Tuesday said it was lifting its weekslong export ban on Anthropic's powerful artificial-intelligence model…
Ravi Thanawala was previously chief financial officer of Nike North America from June 2020 to July 2023. "American Eagle Names Ravi Thanawala CFO, Reaffirms 2026 Outlook" published at 4:37 p.m. ET omitted the full location in the name.
-- Source link: https://tinyurl.com/239qs333-- Note: Reuters has not verified this story and does not vouch for its accuracy
AUSTIN, Texas, July 1, 2026 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE:INN) (the "Company") today announced that it will report financial results for the second quarter of 2026 on Wednesday, August 5, 2026, after the market closes.The Company will conduct its quarterly conference call on T…
By Bill Peters'Cat growth is on fire,' one executive saysGeneral Mills' stock jumped on Wednesday but is still down for the year.After making its products cheaper last year, General Mills is now trying to make them better as it seeks to win over increasingly price-conscious consumers and reverse a…
The U.S. government is in advanced talks with AI companies to create voluntary standards for the release of new models, with an announcement possible as soon as next week, the Financial Times reported on Wednesday, citing sources.
Li Auto delivered 30,895 vehicles in June (down 14.8% YoY, 7.4% MoM); YTD deliveries 1,733,687 (up ~29.6%). Li i6 BEV production topped 150,000 in June; new Li L8 rollout set for J
TAKEDA, INSILICO STRIKE AI DRUG-DISCOVERY DEAL WORTH UP TO $600 MILLION - WSJTAKEDA WILL BE GRANTED EXCLUSIVE WORLDWIDE RIGHTS UNDER INSILICO DEAL TO DEVELOP, MANUFACTURE AND COMME
Saunders Mitchell, an officer serving as Chief Accounting Officer, reported a sale of common stock executed on 2026-06-29 in multiple trades at prices ranging from $97.86 to $108.85 with a weighted average sale price of $102.20 per share and total sale proceeds of $1,022,000; after the sale, Saunde…
Steve Pakola, an officer serving as Chief Medical Officer, reported sales under a Rule 10b5-1 trading plan. The transactions were sales of common stock executed on 2026-06-29 and 2026-07-01 at a weighted average price of $12.22 per share (weighted across multiple trades; one sale reported at a weig…
CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced a strategic collaboration with Lonza to develop best-in-class single-domain antibody–based…
